Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
2023-11-08 12:48:09 ET Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Conference Call November 8, 2023 8:00 AM ET Company Participants Ran Meir - Senior Vice President, Investor Relations Richard Francis - President and Chief Executive Officer, Member of the ...
2023-10-25 10:05:00 ET Summary Sound Shore Fund, Inc. is registered as a diversified, open-end management investment company. The investment objective of the Fund is growth of capital. Sound Shore Fund Investor Class and Institutional Class declined in Q3 2023, but still outperfor...
2023-09-11 12:50:27 ET Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 21st Annual Global Healthcare Conference 2023 Call September 11, 2023, 08:40 AM ET Company Participants Richard Francis - Chief Executive Officer Conference Call Participants ...
2023-08-18 13:09:45 ET Summary On August 7, Viatris released its financial results for the 2nd quarter of 2023, which, after a long time, finally managed to beat analysts' expectations. Viatris' revenue for the second quarter of 2023 was $3.92 billion, up 5.1% from the previous qu...
2023-08-02 12:47:07 ET Teva Pharmaceutical Industries Limited (TEVA) Q2 2023 Earnings Conference Call August 2, 2023, 8:00 a.m. ET Company Participants Richard Francis - President & CEO Eli Kalif - CFO Dr. Eric Hughes - CMO, Head of R&D Sven Dethlefs ...
2023-07-23 04:30:00 ET Summary Patient Capital Management are long-term, contrarian, value investors focusing on growing wealth through Time, not Timing. We operate with the singular purpose of serving clients and helping them enhance their long term investment returns. Patient Ca...
2023-07-20 10:43:40 ET Summary On August 2, 2023, Teva Pharmaceutical, one of the world's top generic drug manufacturers, will publish its financial report for the second quarter of 2023. The company has launched generic versions of several medicines and is conducting phase 2 tria...
2023-06-15 13:17:52 ET Summary CVS has seen its shares decline to a pretty low price. The valuation is very undemanding. The yield is high, and the long-term outlook is solid. Article Thesis CVS Health Corporation ( CVS ) has seen its shares slump on comments fro...
2023-06-07 07:00:00 ET Summary Markets overreacted to Norwich suing the FDA. Investors must consider recently reported weak Q1 results of Bausch Health. Reasons BHC stock is a buy from here. Last summer, Bausch Health ( BHC ) traded with wild 11% drops . Vola...
2023-05-10 12:28:06 ET Teva Pharmaceutical Industries Limited (TEVA) Q1 2023 Earnings Conference Call May 10, 2023, 08:00 ET Company Participants Ran Meir - SVP, Investor Relations Richard Francis - President & CEO Eli Kalif - CFO Eric Hughes - Chief Medi...